AAN.com
Quick search in Citations
AnywhereCitation
Advanced Search
Trending Terms:
Case
August 8, 2019

Clinical manifestations of episodic ataxia type 5

Miguel González Sánchez, MD, Silvia Izquierdo, MD, Sara Álvarez, MD, Rosa Eva Bautista Alonso, MD, José Berciano, MD, and José Gazulla, MDAuthors Info & Affiliations
December 2019 issue
9 (6) 503-504
https://doi.org/10.1212/CPJ.0000000000000697
Letters to the Editor
Track CitationsAdd to favorites
Get Access

Abstract

A detailed clinical description of episodic ataxia type 5 will help identify this condition more readily.

Get full access to this article

View all available purchase options and get full access to this article.

Get Access

References

1.
Choi KD, Choi JH. Episodic ataxias: clinical and genetic features. J Mov Disord 2016;9:129–135.
Crossref
PubMed
Google Scholar
2.
Riant F, Vahedi K, Tournier-Lasserve E. Ataxies épisodiques génétiques. Rev Neurol 2011;167:401–407.
PubMed
Google Scholar
3.
Escayg A, De Waard M, Lee DD, et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 2000;66:1531–1539.
Crossref
PubMed
Google Scholar
4.
Setta F, Jacquy J, Hildebrand J, Manto MU. Ataxia induced by small amounts of alcohol. J Neurol Neurosurg Psychiatry 1998;65:370–373.
PubMed
Google Scholar

Information & Authors

Information

Published In

Neurology® Clinical Practice
Volume 9 • Number 6 • December 2019
Pages: 503-504

Copyright

© 2019 American Academy of Neurology.

Publication History

Received: February 26, 2019
Accepted: June 17, 2019
Published online: August 8, 2019
Published in print: December 2019

Permissions

Request permissions for this article.

Disclosure

The authors report no disclosures relevant to the manuscript. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Study Funding

No targeted funding reported.

Authors

Affiliations & Disclosures

Miguel González Sánchez, MD
Department of Neurology (MGS, JG), Hospital Universitario Miguel Servet; Department of Clinical Biochemistry (SI), Hospital Universitario Miguel Servet, Section of Genetics, Zaragoza; NIMGenetics (SA), Madrid; Department of Internal Medicine (REBA), Hospital Universitario Miguel Servet, Zaragoza; Department of Neurology (JB), Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Silvia Izquierdo, MD
Department of Neurology (MGS, JG), Hospital Universitario Miguel Servet; Department of Clinical Biochemistry (SI), Hospital Universitario Miguel Servet, Section of Genetics, Zaragoza; NIMGenetics (SA), Madrid; Department of Internal Medicine (REBA), Hospital Universitario Miguel Servet, Zaragoza; Department of Neurology (JB), Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Journal of Healthcare Quality Research - Elsevier (JHQR), Associate editor, 2010-2019. I not receive compensation.
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Sara Álvarez, MD
Department of Neurology (MGS, JG), Hospital Universitario Miguel Servet; Department of Clinical Biochemistry (SI), Hospital Universitario Miguel Servet, Section of Genetics, Zaragoza; NIMGenetics (SA), Madrid; Department of Internal Medicine (REBA), Hospital Universitario Miguel Servet, Zaragoza; Department of Neurology (JB), Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
Rosa Eva Bautista Alonso, MD
Department of Neurology (MGS, JG), Hospital Universitario Miguel Servet; Department of Clinical Biochemistry (SI), Hospital Universitario Miguel Servet, Section of Genetics, Zaragoza; NIMGenetics (SA), Madrid; Department of Internal Medicine (REBA), Hospital Universitario Miguel Servet, Zaragoza; Department of Neurology (JB), Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
José Berciano, MD
Department of Neurology (MGS, JG), Hospital Universitario Miguel Servet; Department of Clinical Biochemistry (SI), Hospital Universitario Miguel Servet, Section of Genetics, Zaragoza; NIMGenetics (SA), Madrid; Department of Internal Medicine (REBA), Hospital Universitario Miguel Servet, Zaragoza; Department of Neurology (JB), Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author
José Gazulla, MD
Department of Neurology (MGS, JG), Hospital Universitario Miguel Servet; Department of Clinical Biochemistry (SI), Hospital Universitario Miguel Servet, Section of Genetics, Zaragoza; NIMGenetics (SA), Madrid; Department of Internal Medicine (REBA), Hospital Universitario Miguel Servet, Zaragoza; Department of Neurology (JB), Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
Associated Professor of Neurology at the University of Zaragoza, Spain.
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
View all articles by this author

Notes

Correspondence Dr. González Sánchez [email protected]
Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
    • Rupam Borgohain,
    • Sai Deepak Yaranagula,
    • Sruthi Kola,
    • Rukmini Mridula Kandadai,
    • Tazeem Syed Fathima,
    • V.V.S.R.K. Prasad,
    • Rajesh Alugolu,
    Episodic Ataxias, Reference Module in Neuroscience and Biobehavioral Psychology, (2024).https://doi.org/10.1016/B978-0-323-95702-1.00144-5
    Crossref
    • Tracey D. Graves,
    • Heather D. Snell,
    • Kamran Khodakhah,
    • Robert C. Griggs,
    • Joanna C. Jen,
    The episodic ataxias, Neurologic Channelopathies, (123-133), (2024).https://doi.org/10.1016/B978-0-323-90820-7.00012-4
    Crossref
    • Roberto Erro,
    • Francesca Magrinelli,
    • Kailash P. Bhatia,
    Paroxysmal movement disorders: Paroxysmal dyskinesia and episodic ataxia, Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment, (347-365), (2023).https://doi.org/10.1016/B978-0-323-98817-9.00033-8
    Crossref
    • Mahesh Padmanaban,
    • Christopher M. Gomez,
    Ion Channel Genes and Ataxia, Trials for Cerebellar Ataxias, (209-261), (2023).https://doi.org/10.1007/978-3-031-24345-5_7
    Crossref
    • Tatiana O. Kolesnikova,
    • Konstantin A. Demin,
    • Fabiano V. Costa,
    • Konstantin N. Zabegalov,
    • Murilo S. de Abreu,
    • Elena V. Gerasimova,
    • Allan V. Kalueff,
    Towards Zebrafish Models of CNS Channelopathies, International Journal of Molecular Sciences, 23, 22, (13979), (2022).https://doi.org/10.3390/ijms232213979
    Crossref
    • Stephan Lauxmann,
    • Lukas Sonnenberg,
    • Nils A. Koch,
    • Christian Bosselmann,
    • Natalie Winter,
    • Niklas Schwarz,
    • Thomas V. Wuttke,
    • Ulrike B. S. Hedrich,
    • Yuanyuan Liu,
    • Holger Lerche,
    • Jan Benda,
    • Josua Kegele,
    Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in KCNA1-Associated Episodic Ataxia and a Comprehensive Review of the Literature, Frontiers in Neurology, 12, (2021).https://doi.org/10.3389/fneur.2021.703970
    Crossref
    • Giacomo Garone,
    • Alessandro Capuano,
    • Lorena Travaglini,
    • Federica Graziola,
    • Fabrizia Stregapede,
    • Ginevra Zanni,
    • Federico Vigevano,
    • Enrico Bertini,
    • Francesco Nicita,
    Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias, International Journal of Molecular Sciences, 21, 10, (3603), (2020).https://doi.org/10.3390/ijms21103603
    Crossref
    • Wojciech Koźmiński,
    • Joanna Pera,
    Involvement of the Peripheral Nervous System in Episodic Ataxias, Biomedicines, 8, 11, (448), (2020).https://doi.org/10.3390/biomedicines8110448
    Crossref

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share

View full text|Download PDF